Filing Details
- Accession Number:
- 0001181431-12-042954
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-01 13:52:58
- Reporting Period:
- 2012-07-30
- Filing Date:
- 2012-08-01
- Accepted Time:
- 2012-08-01 13:52:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885306 | Cynosure Inc | CYNO | Electromedical & Electrotherapeutic Apparatus (3845) | 043125110 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1345794 | J Douglas Delaney | C/O Cynosure, Inc. 5 Carlisle Road Westford MA 01886 | Executive Vp, Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2012-07-30 | 32,782 | $7.84 | 32,782 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2012-07-30 | 24,512 | $23.93 | 8,270 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2012-07-30 | 7,270 | $24.03 | 1,000 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2012-07-30 | 1,000 | $24.17 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Employer Stock Option (right to buy) | Disposition | 2012-07-30 | 32,782 | $0.00 | 32,782 | $7.84 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-02-11 | No | 4 | M | Direct |
Footnotes
- The option became exercisable as to approximately 8.33% of the shares on each three-month anniversary of the date of grant.